Research Article

Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines

Table 5

Biochemical effects following Xylazine-butorphanol-Guaifenesin-Ketamine anaesthesia in Spiti ponies ( 𝑛 = 6 ).

Parameters (unit)Before induction (BI)After induction (AI)During anaesthesia (DAn)After recovery (AR)

Sodium (mEq/L)128.05 ± 11.70122.80 ± 11.16113.93 ± 5.32109.80 ± 5.72
Potassium (mEq/L)4.17 ± 0.393.93 ± 0.294.12 ± 0.693.29 ± 0.31
Chloride (mEq/L)79.15 ± 12.4481.30 ± 7.5084.39 ± 9.4777.41 ± 5.43
Glucose (mg/dL)75.50 ± 11.03119.17 ± 14.77125.66 ± 13.66120.83 ± 13.42
Total proteins (g/dL)8.60 ± 0.4910.60 ± 0.4910.83 ± 0.6110.36 ± 1.06
AST (U/L)241.00 ± 29.24200.33 ± 25.39176.83 ± 29.37169.16 ± 29.78
ALT (U/L)13.60 ± 0.6318.92** ± 0.6018.44** ± 0.6213.18 ± 0.71
ALKP(U/L)123.00 ± 4.12138.00* ± 3.54111.17 ± 2.48118.50 ± 3.56
BUN (mg/dL)25.70 ± 2.9724.33 ± 2.1823.28 ± 1.6622.05 ± 1.98
Creatinine (mg/dL)0.81 ± 0.050.74 ± 0.050.78 ± 0.060.84 ± 0.14

𝑃 < . 0 5 ; 𝑃 < . 0 1 .